Health Affairs October 25, 2024
Jeffrey G. Willett, Maher Karam-Hage

For six decades following the 1964 surgeon general’s report on smoking, public health and industry have implemented opposing strategies regarding the marketing and sale of tobacco products. Despite progress, smoking-attributable mortality remains a leading cause of preventable death, and concerning disparities in tobacco use prevalence exist, particularly among the 28.3 million US adults who smoke cigarettes. Recently, the emergence of e-cigarettes, oral nicotine pouches, and other novel tobacco products have created intense disagreements regarding how tobacco control can best improve public health. In this environment, decisions being made by policy makers, regulators, and industry will determine whether the US will continue to see a slow and inequitable reduction in tobacco-related deaths, or bolder action is taken to more rapidly reduce...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Public Health / COVID
5 Things You Should Know About Long COVID
The surprising effect COVID-19 could have on cancer
Policy Experts Split on Dr. Oz Nomination to Lead CMS
Surgeon general says U.S. smoking rates have tumbled, but not for everyone
Research highlights disparities in heart disease, stroke trends worldwide

Share This Article